nach oben

BioDrugs

Erschienen in:

01.08.2001 | Leading Article

A Vaccine against Dental Caries

An Overview

verfasst von: Dr Suzanne M. Michalek, Jannet Katz, Noel K. Childers

Erschienen in: BioDrugs | Ausgabe 8/2001

Einloggen, um Zugang zu erhalten

Abstract

Dental caries continues to be a costly and prevalent oral disease. Research efforts towards developing a well tolerated and effective vaccine against dental caries were initiated following the demonstration of a specific bacterial aetiology for this disease. The cariogenic mutans streptococci are the principal bacteria causing this disease. Specific immune defence against these bacteria is provided mainly by secretory immunoglobulin (Ig) A antibodies present in saliva, which are generated by the common mucosal immune system. Progress in the development of a vaccine against dental caries has increased due to both advancements in molecular biology and our understanding of the mucosal immune system and mucosal vaccines. Advancements in molecular biology have facilitated the cloning and functional characterisation of virulence factors of the mutans streptococci, including the cell-surface fibrillar proteins, which mediate adherence to the tooth surface, and the glucosyltransferase enzymes, which synthesise adhesive glucans and allow microbial accumulation on the teeth.

Current strategies for immunisation against dental caries are using these virulence factors as key antigens and incorporating them into novel mucosal vaccine systems and delivering them with or without adjuvants to mucosal IgA inductive sites. The most popular routes of mucosal immunisation are via the oral or nasal route. The mucosal immune system is functional in newborn infants, who develop salivary IgA antibodies as they become colonised by oral micro-organisms. Mucosal immunisation strategies result in the induction of salivary IgA antibody responses and pose fewer problems than parenteral injection of antigen. Therefore, mucosal immunisation of infants prior to the appearance of their first teeth may be a well tolerated and effective way to induce immunity against the colonisation of teeth by mutans streptococci and protection against subsequent dental caries. The purpose of this article is to provide an overview of the recent progress on the development of a vaccine against infection by Streptococcus mutans for the prevention of dental caries, with emphasis on the mucosal immune system and vaccine design.

Loesche WJ. Role of Streptococcus mutans in human dental decay. Microbiol Rev 1986; 50: 353–80PubMed

Hajishengallis G, Michalek SM. Current status of a mucosal vaccine against dental caries. Oral Microbiol Immunol 1999; 14: 1–20CrossRefPubMed

Michalek SM, Childers NK. Development and outlook for a caries vaccine. Crit Rev Oral Biol Med 1990; 1: 37–54PubMed

Russell MW, Hajishengallis G, Childers NK, et al. Secretory immunity in defense against cariogenic mutans streptococci. Caries Res 1999; 33: 4–15CrossRefPubMed

Smith DJ, Taubman MA. Vaccines against dental caries infection. In: Levine MM, Woodrow GC, Kaper JB, et al. editors. New generation vaccines. New York: Marcel Dekker, Inc., 1997: 913–30

Brandtzaeg P. Salivary immunoglobulins. In: Tenovuo JO, editor. Human saliva: Clinical chemistry and microbiology. Bca Raton (FL): CRC Press, 1989: 1–54

Tomasi TB, Tan EM, Solomon A, et al. Characteristics of an immune system common to certain external secretions. J Exp Med 1965; 121: 101–24CrossRefPubMed

Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 1987; 7: 265–76CrossRefPubMed

Ogra PL, Mestecky J, Lamm ME, et al. Mucosal immunology. 2nd ed. Sn Diego (CA): Academic Press, 1999

10.

Brandtzaeg P. Overview of the mucosal immune system. Curr Top Microbiol Immunol 1989; 146: 13–25CrossRefPubMed

11.

McGhee JR, Mestecky J, Dertzbaugh MT, et al. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992; 10: 75–88CrossRefPubMed

12.

Mestecky J, Abraham R, Ogra PL. Common mucosal immune system and strategies for the development of vaccines effective at the mucosal surface. In: Ogra PL, Mestecky J, Lamm ME, et al. editors. Handbook of mucosal immunology. San Diego (CA): Academic Press, Inc., 1994: 357–72

13.

Craig SW, Cebra JJ. Peyer’s patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J Exp Med 1971; 134: 188–200CrossRefPubMed

14.

Michalek SM, McGhee JR, Mestecky J, et al. Ingestion of Streptococcus mutans induces secretory immunoglobulin A and caries immunity. Science 1976; 192: 1238–40CrossRefPubMed

15.

Montgomery PC, Cohn J, Lally ET. The induction and characterization of secretory IgA antibodies. Adv Exp Med Biol 1974; 45: 453–62PubMed

16.

Czerkinsky C, Prince SJ, Michalek SM, et al. IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci USA 1987; 84: 2449–53CrossRefPubMed

17.

Czerkinsky C, Svennerholm AM, Quiding M, et al. Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans. Infect Immun 1991; 59: 996–1001PubMed

18.

Mestecky J, McGhee JR, Arnold RR, et al. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest 1978; 61: 731–7CrossRefPubMed

19.

Brandtzaeg P, Baekkevold ES, Farstad IN, et al. Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol Today 1999; 20: 141–51CrossRefPubMed

20.

Brown TA, Mestecky J. Immunoglobulin A subclass distribution of naturally occurring salivary antibodies to microbial antigens. Infect Immun 1985; 49: 459–62PubMed

21.

Brown TA, Murphy BR, Radl J, et al. Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol 1985; 22: 259–64PubMed

22.

Moldoveanu Z, Russell MW, Wu HY, et al. Compartmentalization within the common mucosal immune system. In: Jackson S, Kiyono H, McGhee JR, et al. editors. Advances in mucosal immunology. Nw York: Plenum Press Publishing Corporation, 1995: 97–101

23.

Russell MW, Moldoveanu Z, White PL, et al. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and cholera toxin B subunit. Infect Immun 1996; 64: 1272–83PubMed

24.

Czerkinsky C, Russell MW, Lycke N, et al. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun 1989; 57: 1072–7PubMed

25.

Smith DJ, Taubman MA. Oral immunization of humans with Streptococcus sobrinus glucosyltransferase. Infect Immun 1987; 55: 2562–9PubMed

26.

Hajishengallis G, Russell MW, Michalek SM. Comparison of an adherence domain and a structural region of Streptococcus muians antigen I/II in protective immunity against dental caries in rats after intranasal immunization. Infect Immun 1998; 66: 1740–3PubMed

27.

Katz J, Harmon CC, Buckner GP, et al. Protective salivary immunoglobulin A responses against Streptococcus mutons infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin. Infect Immun 1993; 61: 1964–71PubMed

28.

Wu H-Y, Russell MW. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun 1993; 61: 314–22PubMed

29.

Childers NK, Tong G, Mitchell S, et al. A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses. Infect Immun 1999;67: 618–23PubMed

30.

Kuper CF, Koornstra PJ, Hameleers DM, et al. The role of nasopharyngeal lymphoid tissue. Immunol Today 1992; 13: 219–24CrossRefPubMed

31.

Wu H-Y, Russell MW. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol Res 1997; 16: 187–201CrossRefPubMed

32.

Brandtzaeg P, Haneberg B. Role of nasal-associated lymphoid tissue in the human mucosal immune system. Mucosal Immunol Update 1997; 5: 4–8

33.

Howie AJ. Scanning and transmission electron microscopy on the epithelium of human palatine tonsils. J Pathol 1980; 130: 91–8CrossRefPubMed

34.

Hameleers DM, Stoop AE, van der Ven I, et al. Intra-epithelial lymphocytes and non-lymphoid cells in the human nasal mucosa. Int Arch Allergy Appl Immunol 1989; 88: 317–22CrossRefPubMed

35.

Ishikawa T. Nasal immunologic reactivity, rhinitis, and polyps. In: Ogra PL, Mestecky J, Lamm ME, et al. editors. Mucosal immunology. Sn Diego (CA): Academic Press, 1999: 1293–304

36.

Winther B, Innes Jr DJ, Mills SE, et al. Lymphocyte subsets in normal airway mucosa of the human nose. Arch Otolaryngol Head Neck Surg 1987; 113: 59–62CrossRefPubMed

37.

Sertl K, Takemura T, Tschachler E, et al. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J Exp Med 1986; 163: 436–51CrossRefPubMed

38.

Clements ML, Murphy BR. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol 1986; 23: 66–72PubMed

39.

Hamada S, Slade HD. Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev 1980; 44: 331–84PubMed

40.

Kuramitsu HK. Virulence factors of mutans streptococci: role of molecular genetics. Crit Rev Oral Biol Med 1993; 4: 159–76PubMed

41.

Curtiss R, III. Genetic analysis of Streptococcus mutans virulence and prospects for an anticaries vaccine. J Dent Res 1986; 65: 1034–45CrossRefPubMed

42.

Jenkinson HE, Lamont RJ. Streptococcal adhesion and colonization. Crit Rev Oral Biol Med 1997; 8: 175–200CrossRefPubMed

43.

Russell MW. Immunization against dental caries. Curr Opin Dent 1992; 2: 72–80PubMed

44.

McGhee JR, Michalek SM, Webb J, et al. Effective immunity to dental caries: protection of gnotobiotic rats by local immunization with Streptococcus mutans. J Immunol 1975; 114: 300–5PubMed

45.

Taubman MA, Smith DJ. Effects of local immunization with Streptococcus mutans on induction of salivary immunoglobulin A antibody and experimental dental caries in rats. Infect Immun 1974; 9: 1079–91

46.

Michalek SM, McGhee JR, Babb JL. Effective immunity to dental caries: dose-dependent studies of secretory immunity by oral administration of Streptococcus mutans to rats. Infect Immun 1978; 19: 217–24PubMed

47.

Michalek SM, Morisaki I, Harmon CC, et al. Effective immunity to dental caries: gastric intubation of Streptococcus mutans whole cells or cell walls induces protective immunity in gnotobiotic rats. Infect Immun 1983; 39: 645–54PubMed

48.

Hajishengallis G, Hollingshead SK, Koga T, et al. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol 1995; 154: 4322–32PubMed

49.

Harokopakis E, Hajishengallis G, Greenway TE, et al. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits. Infect Immun 1997; 65: 1445–54PubMed

50.

Huang Y, Hajishengallis G, Michalek SM. Construction and characterization of a Salmonella enterica serovar Typhimurium clone expressing a salivary adhesin of Streptococcus mutans under control of the anaerobically inducible nirB promoter. Infect Immun 2000; 68: 1549–56CrossRefPubMed

51.

Huang Y, Hajishengallis G, Michalek SM. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar Typhimurium expressing a S. mutans adhesin under the control of the in vivo inducible nirB promoter. Infect Immun 2001; 69: 2154–61CrossRefPubMed

52.

Hormaeche CE, Khan CMA, Mastroeni P, et al. Salmonella vaccines: mechanisms of immunity and their use as carriers of recombinant antigens. In: Ala’Aldeen D, Hormaeche CE, editors. Molecular and clinical aspects of vaccine development. England: John Wiley and Sons, Ltd, 1995: 119–53

53.

Michalek SM, Eldridge JH, Curtiss RI, et al. Antigen delivery systems: new approach to mucosal immunization. In: Ogra PL, Mestecky J, Lamm ME, et al. editors. Handbook of mucosal immunology. San Diego (CA): Academic Press, Inc., 1994: 373–86

54.

Childers NK, Zhang SS, Harokopakis E, et al. Properties of practical oral liposome-Streptococcus mutans glucosyl-transferase (GTF) vaccines for effective induction of protective immune responses. Oral Microbiol Immunol 1996; 11: 172–80CrossRefPubMed

55.

Smith DJ, Taubman MA. Effect of oral administration of glucosyltransferase antigens on experimental dental caries. Infect Immun 1979; 26: 82–9PubMed

56.

Smith DJ, Shoushtari B, Heschel RL, et al. Immunogenicity and protective immunity induced by synthetic peptides associated with a catalytic subdomain of mutans group streptococcal glucosyltransferase. Infect Immun 1997; 65: 4424–30PubMed

57.

Taubman MA, Holmberg CJ, Smith DJ. Immunization of rats with synthetic peptide constructs from the glucan-binding or catalytic region of mutans streptococcal glucosyltransferase protects against dental caries. Infect Immun 1995; 63: 3088–93PubMed

58.

Taubman MA, Smith DJ, Holmberg CJ, et al. Coimmunization with complementary glucosyltransferase peptides results in enhanced immunogenicity and protection against dental caries. Infect Immun 2000; 68: 2698–703CrossRefPubMed

59.

Jespersgaard C, Hajishengallis G, Huang Y, et al. Protective immunity against Streptococcus mutans infection in mice after intranasal immunization with the glucan-binding region of S. mutans glucosyltransferase. Infect Immun 1999; 67: 6543–9PubMed

60.

Gregory RL, Michalek SM, Filler SJ, et al. Prevention of Streptococcus mutans colonization by salivary IgA. J Clin Immunol 1985; 5: 55–62CrossRefPubMed

61.

Smith DJ, Taubman MA. Effect of local deposition of antigen on salivary immune responses and reaccumulation of mutans streptococci. J Clin Immunol 1990; 10: 273–81CrossRefPubMed

62.

Childers NK, Zhang SS, Michalek SM. Oral immunization of humans with dehydrated liposomes containing Streptococcus mutans glucosyltransferase induces salivary immunoglobulin A2 antibody responses. Oral Microbiol Immunol 1994; 9: 146–53CrossRefPubMed

63.

Kilian M, Russell MW. Function of mucosal immunoglobulin.In: Ogra PL, Mestecky J, Lamm ME, et al. editors. Handbook of mucosal immunology. San Diego (CA): Academic Press, Inc., 1994: 127–37

64.

Childers NK, Tong G, Michalek SM. Nasal immunization of humans with dehydrated liposomes containing Streptococcus mutans antigen. Oral Microbiol Immunol 1997; 12: 329–35CrossRefPubMed

65.

Caufield PW, Cutter GR, Dasanayake AP. Initial acquisition of mutans streptococci by infants: evidence for a discrete window of infectivity. J Dent Res 1993; 72: 37–45CrossRefPubMed

66.

Smith DJ, Taubman MA. Ontogeny of immunity to oral microbiota in humans. Crit Rev Oral Biol Med 1992; 3: 109–33PubMed

67.

Van de Rijn I, Bleiweis AS, Zabriskie JB. Antigens in Streptococcus mutans cross reactive with human heart muscle. J Dent Res 1976; 55: C59–64CrossRefPubMed

68.

Hughes M, Machardy SM, Sheppard AJ, et al. Evidence for an immunological relationship between Streptococcus mutans and human cardiac tissue. Infect Immun 1980; 27: 576–88PubMed

69.

Cunningham MW, Krisher K, Graves DC. Murine monoclonal antibodies reactive with human heart. Infect Immun 1984; 4: 34–41

70.

Van de Rijn I, Zabriskie JB, McCarthy M. Group A streptococcal antigens cross-reactive with myocardium. J Exp Med 1977; 146: 579–99CrossRefPubMed

71.

Russell MW, Wu HY Streptococcus mutans and the problem of heart cross-reactivity. Crit Rev Oral Biol Med 1990; 1: 191–205PubMed

Titel: A Vaccine against Dental Caries
An Overview
verfasst von: Dr Suzanne M. Michalek
Jannet Katz
Noel K. Childers
Publikationsdatum: 01.08.2001
Verlag: Springer International Publishing
Erschienen in: BioDrugs / Ausgabe 8/2001
Print ISSN: 1173-8804
Elektronische ISSN: 1179-190X
DOI: https://doi.org/10.2165/00063030-200115080-00002

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

A Vaccine against Dental Caries

An Overview

Abstract

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2001

Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis

Allergen-Specific Sublingual Immunotherapy for Respiratory Allergy

Co-Stimulatory Blockade and Tolerance Induction in Transplantation

Neuroendocrine and Immune Aspects of Fibromyalgia

The Role of Immunoglobulins in Neonatal Rhesus Haemolytic Disease